Analysts Viewpoint
CDTX’s latest rating updates from top analysts.
Cidara Therapeutics Inc’s recent filing unveils that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $100.0 million
Menu
Cidara Therapeutics Inc’s recent filing unveils that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $100.0 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Cidara Therapeutics Inc’s recently made public that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $100.0 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Cidara Therapeutics Inc revealed its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $100.0 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Cidara Therapeutics Inc’s filing revealed that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $100.0 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Cidara Therapeutics Inc’s recent filing unveils that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $100.0 million